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ABSTRACT
Objective: Laparoscopy is a safe, feasible technique for
benign pancreatic pathologies and has been increasingly
reported for neuroendocrine tumors located at the body
and tail of the pancreas. We report a case of successful
enucleation of a nonfunctioning neuroendocrine tumor
located at the head of the pancreas, in a patient with
multiple endocrine neoplasia type I.
Methods: A 5-cm nonfunctioning neuroendocrine tumor
at the pancreatic head was identified by computerized
tomography scan. Laparoscopic ultrasound did not reveal
additional tumors on any other part of the pancreas.
Results: Enucleation was successfully performed for this
solitary tumor because of its favorable position. Histology
revealed an islet cell tumor. No postoperative complica-
tions occurred and recovery was rapid.
Conclusion: Laparoscopic enucleation of neuroendo-
crine tumor at the pancreatic head is safe and feasible for
select patients.
Key Words: Pancreatic neuroendocrine tumor, Laparos-
copy, Enucleation, Pancreatic head, Multiple endocrine
neoplasia type I, Outcome.
INTRODUCTION
Laparoscopic resection of the pancreas has been increas-
ingly reported for benign pancreatic pathologies. Most of
these reports have described the safety and feasibility of
laparoscopic pancreatic resection for benign pancreatic
lesions including neuroendocrine tumors located at the
body or tail of pancreas.1–5 Enucleation was preferred to
resection for neuroendocrine tumors located at the pan-
creatic head, because of the commonly benign nature of
the tumor and the need to preserve pancreatic function.
However, attempts at laparoscopic resection of neuroen-
docrine tumors located at the head of the pancreas were
not infrequently converted to an open procedure due to
technical difficulties or the inability to localize the tumor
during laparoscopy.1,6
We report a case of successful laparoscopic enucleation of
a nonfunctioning neuroendocrine tumor located at the
head of the pancreas, in a patient with multiple endocrine
neoplasia type I (MEN I) syndrome. To our knowledge,
only 2 previous reports exist on successful laparoscopic
enucleation of insulinoma at the head of the pancreas1,5
but none on nonfunctioning neuroendocrine tumors.
CASE REPORT
A 26-year-old Chinese woman was diagnosed with MEN I
syndrome based on a positive family history and the pres-
ence of associated endocrinopathies. She had hyperpro-
lactinemia due to a pituitary micro-adenoma and had also
undergone a subtotal parathyroidectomy for parathyroid hy-
perplasia. She presented with a ruptured left ovarian cyst. A
right ovarian cystectomy and a left salpingo-oophorectomy
were performed. A histological examination showed a tera-
toma with a small carcinoid component in the left ovary.
Postoperative computed tomography revealed an incidental
mass lesion located at the pancreatic head (Figure 1).
The patient’s subsequent workup indicated normal hema-
tology and clinical chemistry. Her hormonal profile re-
vealed a mildly elevated chromogranin A level of 21 U/L
(normal 2 U/L to 18 U/L) but normal fasting levels of
insulin, gastrin, glucagon, somatostatin, and neuron-
specific enolase. Urine for 5-hyroxyindole acetic acid
(HIAA) was within normal limits. Preoperative endoscopic
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CASE REPORTultrasonography failed to confirm the location of the pan-
creatic head lesion. Laparoscopy with the aim of pancre-
atectomy was planned. Laparoscopy was performed using
four 11-mm ports with the patient in the supine position
(Figure 2). A 5x4-cm tumor was found located at the
anteroinferior surface of the head of the pancreas medial
to the gastroduodenal artery (Figure 3). A laparoscopic
ultrasound probe 10 mm in diameter with a frequency of
8 MHz (Sharplan, Honey–Vclave Medical, NJ, USA) was
performed to delineate the location of the tumor in rela-
tion to the pancreatic duct, and to detect any additional
tumors located on the body and tail of pancreas (Figure
3). Enucleation under laparoscopy was chosen because of
the favorable anatomic position of the tumor and the
absence of multiple tumors on the body and tail of the
pancreas. With the combined use of hook cautery and
ultrasonic dissector (Olympus Sonosurg, Olympus Optical
Company Limited, Tokyo, Japan), the tumor was enucle-
ated uneventfully (Figure 4). Fibrin glue (Tissel/Tissucol
TM, Immuno AG, Vienna) was sprayed to the enucleated
surface of the pancreas, and an omental patch was used to
reinforce the enucleated site. The operative time was 165
minutes with an estimated blood loss of 50 mL. A silicone
closed-suction drain was inserted next to the enucleated
pancreatic bed. Postoperative recovery was uneventful
Figure 1. Computed tomographic scan showing a neuroendo-
crine tumor at the head of the pancreas in the patient.
Figure 2. Postoperative photograph taken at one month after
the operation to illustrate the position of the port sites (illustrated
by arrows).
Figure 3. Intraoperative photo of the tumor located at the head
of the pancreas (A) and the laparoscopic ultrasonographic ap-
pearance of the tumor as pointed out by big arrow and its
relationship to the pancreatic duct as shown by the small arrow
(B).
Figure 4. Photo of the resected specimen showing a 5x4x2.5-cm
well-circumscribed fleshy pancreatic neuroendocrine tumor.
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moved on postoperative day 3, and the patient was dis-
charged on the same evening. The histopathology re-
vealed an islet cell tumor with no vascular invasion and
the margins were clear of tumor. Immunophenotyping
was strongly positive for chromogranin, with focal posi-
tivity for insulin, somatostatin, and serotonin. The serum
chromogranin A level returned to normal (8.0 U/L) at 1
month, and no evidence of recurrence was found at 6
months.
DISCUSSION
Pancreatic endocrine tumors (PET) not associated with
any clinical symptom of hormone oversecretion are clas-
sified as nonfunctioning. They are rare but account for
15% to 50% of PET, and approximately 5% to 10% of MEN
I patients develop nonfunctioning PETs during the course
of the disease. The majority of nonfunctioning tumors
arise at the head of the pancreas, and conventionally, a
Whipple¡ s procedure is frequently advocated for these
tumors.7 For tumors of the endocrine pancreas, the surgi-
cal approach adopted aims at complete resection of the
tumor with maximal preservation of normal pancreatic
tissue.7 Solitary benign nonfunctioning neuroendocrine
tumors of the pancreas can be removed by enucleation or
by pancreatic sparing surgery.8 For multiple benign non-
functioning neuroendocrine tumors of the pancreas in
MEN 1 patients, controversy exists as to the optimal treat-
ment, and a conservative single or multiple enucleation
competes with a more radical resection or partial pancre-
atectomy.2 Reports exist of open simple enucleation of
multiple PET with varying degree of success in MEN 1
patients,9,10 although controversy still exists with regard to
the adoption of laparoscopy and laparoscopic pancreate-
ctomy for PET in MEN 1 patients.
Laparoscopic resection of pancreatic islet cell tumors was
first described in 1996.3 Since then, an increasing number
of reports have been published on successful laparo-
scopic partial pancreatectomy and enucleation for PET.1–6
With the advancement in better preoperative imaging
techniques and intraoperative localization with laparo-
scopic ultrasound, open exploration with bimanual pal-
pation of the pancreas may not be absolutely necessary.
Recent reports on the use of laparoscopic ultrasound have
shown a success rate of 80% to 100% in efficiently local-
izing and outlining the margins of pancreatic tumors.4–6
This has enabled the surgeon to apply a more focused
approach based on the intraoperative findings guided by
laparoscopic ultrasound. Although laparoscopic ultra-
sonography seems to obviate the need for exploring the
entire pancreas to detect multiple tumors, its accuracy
should be evaluated further.
Laparoscopic enucleation of PET located at the head of
the pancreas infrequently require conversion to an open
surgical procedure because of the unfavorable location of
the tumor or the inability to locate the tumors.1,6 There
have only been 2 reports of successful enucleation of an
insulinoma from the head of the pancreas, but the exact
position of the tumor at the head of the pancreas has not
been described.2,4 On the other hand, laparoscopic pan-
creatic resection is safe and feasible for insulinomas lo-
cated on the body and tail of the pancreas.5 In this case,
we attempted to apply this technique to a PET located at
the head of the pancreas. Laparoscopic enucleation of the
solitary PET was feasible in this patient because of
the favorable position and solitary nature of the tumor.
The use of laparoscopic ultrasound to identify the tumor
and to determine its relation to the pancreatic duct has
contributed to surgical success. The return of the levels of
chromogranin A, which is a sensitive marker of PET in
MEN I patients,11 back to normal indirectly reflects the
effectiveness of the surgical treatment. However, fol-
low-up surveillance with imaging and endoscopic ultra-
sonography is necessary to monitor the development of
additional tumors, especially at the body and tail of the
pancreas due to the multicentric and multifocal nature of
the disease process.
CONCLUSION
Laparoscopic enucleation of neuroendocrine tumors of
the pancreatic head is safe and feasible for select patients.
It can be applied to patients with MEN I syndrome, and
this procedure can be combined with a distal subtotal
pancreatectomy. This operative strategy offers all the ben-
efits of minimally invasive surgery when it can be success-
fully performed.
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